The company has informed NICE that it will not provide an evidence submission for this appraisal.
Therefore, we are suspending the appraisal while we consider the next steps
Status | Suspended |
Technology type | Medicine |
Decision | Selected |
Process | TA |
ID number | 3789 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
01 March 2022 | Suspended. The company has informed NICE that it will not provide an evidence submission for this appraisal. Therefore, we are suspending the appraisal while we consider the next steps |
13 May 2021 | Timelines for this appraisal are to be confirmed. Further information regarding the scheduling of this appraisal will be available in due course. |
20 April 2021 (14:00) | Scoping workshop |
01 March 2021 - 29 March 2021 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual